Search Results

LY-2090314 1 mg  | ≥98%

LKT Laboratories, Inc.

GSK-3 inhibitor.

More Information Supplier Page

×

LY-2090314

A66 10 mg  | ≥98%

LKT Laboratories, Inc.

p110α PI3K inhibitor.

More Information Supplier Page

×

A66

A66 5 mg  | ≥98%

LKT Laboratories, Inc.

p110α PI3K inhibitor.

More Information Supplier Page

×

A66

A66 1 mg  | ≥98%

LKT Laboratories, Inc.

p110α PI3K inhibitor.

More Information Supplier Page

×

A66

AS-252424 10 mg  | ≥98%

LKT Laboratories, Inc.

p110γ PI3K inhibitor, potential TRPC1/5/6 negative modulator, potential TRPC3/7 positive modulator.

More Information Supplier Page

×

AS-252424

AS-252424 5 mg  | ≥98%

LKT Laboratories, Inc.

p110γ PI3K inhibitor, potential TRPC1/5/6 negative modulator, potential TRPC3/7 positive modulator.

More Information Supplier Page

×

AS-252424

Palomid 529 10 mg  | ≥98%

LKT Laboratories, Inc.

mTOR inhibitor.

More Information Supplier Page

×

Palomid 529

Palomid 529 5 mg  | ≥98%

LKT Laboratories, Inc.

mTOR inhibitor.

More Information Supplier Page

×

Palomid 529

Palomid 529 50 mg  | ≥98%

LKT Laboratories, Inc.

mTOR inhibitor.

More Information Supplier Page

×

Palomid 529

PIK-293 10 mg  | ≥98%

LKT Laboratories, Inc.

p110δ PI3K inhibitor.

More Information Supplier Page

×

PIK-293